4//SEC Filing
Khouzami Carim V 4
Accession 0001109357-24-000033
CIK 0001109357other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:10 PM ET
Size
27.7 KB
Accession
0001109357-24-000033
Insider Transaction Report
Form 4
EXELON CORPEXC
Khouzami Carim V
CEO of BGE
Transactions
- Tax Payment
Common Stock
2024-01-29$35.29/sh−9,831$346,936→ 23,453 total - Award
2024 Restricted Stock Units
2024-01-29+7,721→ 7,721 total→ Common Stock (7,721 underlying) - Exercise/Conversion
2023 Restricted Stock Units
2024-01-29−2,251→ 4,503 total→ Common Stock (2,251 underlying) - Exercise/Conversion
Common Stock
2024-01-29+3,046→ 12,048 total - Exercise/Conversion
Common Stock
2024-01-29+21,236→ 33,284 total - Disposition to Issuer
Common Stock
2024-01-29$35.29/sh−7,048$248,724→ 16,405 total - Exercise/Conversion
Common Stock
2024-01-29+2,251→ 6,749 total - Exercise/Conversion
Common Stock
2024-01-29+2,253→ 9,002 total - Exercise/Conversion
2021 Restricted Stock Units
2024-01-29−3,046→ 0 total→ Common Stock (3,046 underlying) - Award
2021-2023 Performance Shares
2024-01-29+21,236→ 21,236 total→ Common Stock (21,236 underlying) - Exercise/Conversion
2021-2023 Performance Shares
2024-01-29−21,236→ 0 total→ Common Stock (21,236 underlying) - Exercise/Conversion
2022 Restricted Stock Units
2024-01-29−2,253→ 2,252 total→ Common Stock (2,253 underlying)
Holdings
- 760
Deferred phantom share equivalents
→ Common Stock (760 underlying) - 8,757
Common Stock 401k
Footnotes (8)
- [F1]Restricted stock unit (RSU) award granted under the Exelon LTIP. Award vests in 1/3 increments at the January or February meeting of the Exelon Comp. Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment and the additional RSUs vest on the same schedule as the underlying award.
- [F2]Performance share award granted under the Exelon LTIP for the three-year performance period referenced in Column 1 based upon the Comp. Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share or the cash equivalent of one share pursuant to the Plan's terms with respect to individual stock ownership levels. Performance share awards vest immediately on their grant date.
- [F3]Balance as of December 31, 2023.
- [F4]Pre-vesting balance includes 238 shares acquired through automatic dividend reinvestment during 2023.
- [F5]Pre-vesting balance includes 159 shares acquired through automatic dividend reinvestment during 2023.
- [F6]Pre-vesting balance includes 107 shares acquired through automatic dividend reinvestment during 2023.
- [F7]Balance includes 26 additional phantom share equivalents that were accrued through automatic dividend reinvestment during 2023.
- [F8]Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. The stock fund is a unitized fund that consists of both Exelon common stock and short-term liquid investments. Units of the fund are acquired through quarter-end contributions and dividend reinvestment and will be settled for cash upon the termination of the reporting person. The balance of phantom share equivalents may fluctuate due to changes in the value of the fund units.
Documents
Issuer
EXELON CORP
CIK 0001109357
Entity typeother
Related Parties
1- filerCIK 0001796581
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:10 PM ET
- Size
- 27.7 KB